Ontology type: schema:ScholarlyArticle Open Access: True
2021-11-29
AUTHORSDeirdre Weymann, Janessa Laskin, Steven J. M. Jones, Robyn Roscoe, Howard J. Lim, Daniel J. Renouf, Kasmintan A. Schrader, Sophie Sun, Stephen Yip, Marco A. Marra, Dean A. Regier
ABSTRACTGenomic research is driving discovery for future population benefit. Limited evidence exists on immediate patient and health system impacts of research participation. This study uses real-world data and quasi-experimental matching to examine early-stage cost and health impacts of research-based genomic sequencing. British Columbia’s Personalized OncoGenomics (POG) single-arm program applies whole genome and transcriptome analysis (WGTA) to characterize genomic landscapes in advanced cancers. Our cohort includes POG patients enrolled between 2014 and 2015 and 1:1 genetic algorithm–matched usual care controls. We undertake a cost consequence analysis and estimate 1-year effects of WGTA on patient management, patient survival, and health system costs reported in 2015 Canadian dollars. WGTA costs are imputed and forecast using system of equations modeling. We use Kaplan-Meier survival analysis to explore survival differences and inverse probability of censoring weighted linear regression to estimate mean 1-year survival times and costs. Non-parametric bootstrapping simulates sampling distributions and enables scenario analysis, revealing drivers of incremental costs, survival, and net monetary benefit for assumed willingness to pay thresholds. We identified 230 POG patients and 230 matched controls for cohort inclusion. The mean period cost of research-funded WGTA was $26,211 (SD: $14,191). Sequencing costs declined rapidly, with WGTA forecasts hitting $13,741 in 2021. The incremental healthcare system effect (non-research expenditures) was $5203 (95% CI: 75, 10,424) compared to usual care. No overall survival differences were observed, but outcome heterogeneity was present. POG patients receiving WGTA-informed treatment experienced incremental survival gains of 2.49 months (95% CI: 1.32, 3.64). Future cost consequences became favorable as WGTA cost drivers declined and WGTA-informed treatment rates improved to 60%. Our study demonstrates the ability of real-world data to support evaluations of only-in-research health technologies. We identify situations where precision oncology research initiatives may produce survival benefit at a cost that is within healthcare systems’ willingness to pay. This economic evidence informs the early-stage healthcare impacts of precision oncology research. More... »
PAGES1-16
http://scigraph.springernature.com/pub.10.1007/s12687-021-00557-w
DOIhttp://dx.doi.org/10.1007/s12687-021-00557-w
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1143446021
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/34843087
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Biological Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0604",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Genetics",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Canadian Centre for Applied Research in Cancer Control, Cancer Control Research, BC Cancer Research Centre, 675 West 10th Avenue, V5Z 1L3, Vancouver, BC, Canada",
"id": "http://www.grid.ac/institutes/grid.248762.d",
"name": [
"Canadian Centre for Applied Research in Cancer Control, Cancer Control Research, BC Cancer Research Centre, 675 West 10th Avenue, V5Z 1L3, Vancouver, BC, Canada"
],
"type": "Organization"
},
"familyName": "Weymann",
"givenName": "Deirdre",
"id": "sg:person.01115505661.36",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01115505661.36"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada",
"id": "http://www.grid.ac/institutes/grid.17091.3e",
"name": [
"Division of Medical Oncology, BC Cancer, Vancouver, Canada",
"Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada"
],
"type": "Organization"
},
"familyName": "Laskin",
"givenName": "Janessa",
"id": "sg:person.01252152351.58",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252152351.58"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Molecular Biology & Biochemistry, Simon Fraser University, Burnaby, Canada",
"id": "http://www.grid.ac/institutes/grid.61971.38",
"name": [
"Canada\u2019s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada",
"Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, Canada",
"Department of Molecular Biology & Biochemistry, Simon Fraser University, Burnaby, Canada"
],
"type": "Organization"
},
"familyName": "Jones",
"givenName": "Steven J. M.",
"id": "sg:person.011076371162.80",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011076371162.80"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Canada\u2019s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada",
"id": "http://www.grid.ac/institutes/grid.434706.2",
"name": [
"Canada\u2019s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada"
],
"type": "Organization"
},
"familyName": "Roscoe",
"givenName": "Robyn",
"id": "sg:person.014777661137.06",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014777661137.06"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada",
"id": "http://www.grid.ac/institutes/grid.17091.3e",
"name": [
"Division of Medical Oncology, BC Cancer, Vancouver, Canada",
"Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada"
],
"type": "Organization"
},
"familyName": "Lim",
"givenName": "Howard J.",
"id": "sg:person.01022072546.74",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022072546.74"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada",
"id": "http://www.grid.ac/institutes/grid.17091.3e",
"name": [
"Division of Medical Oncology, BC Cancer, Vancouver, Canada",
"Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada"
],
"type": "Organization"
},
"familyName": "Renouf",
"givenName": "Daniel J.",
"id": "sg:person.0757004616.26",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0757004616.26"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Molecular Oncology, BC Cancer, Vancouver, Canada",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, Canada",
"Department of Molecular Oncology, BC Cancer, Vancouver, Canada"
],
"type": "Organization"
},
"familyName": "Schrader",
"givenName": "Kasmintan A.",
"id": "sg:person.01330657763.71",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330657763.71"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada",
"id": "http://www.grid.ac/institutes/grid.17091.3e",
"name": [
"Division of Medical Oncology, BC Cancer, Vancouver, Canada",
"Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada"
],
"type": "Organization"
},
"familyName": "Sun",
"givenName": "Sophie",
"id": "sg:person.0643127034.07",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643127034.07"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Pathology, BC Cancer, Vancouver, Canada",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department of Pathology & Laboratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada",
"Department of Pathology, BC Cancer, Vancouver, Canada"
],
"type": "Organization"
},
"familyName": "Yip",
"givenName": "Stephen",
"id": "sg:person.0745471507.67",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0745471507.67"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, Canada",
"id": "http://www.grid.ac/institutes/grid.17091.3e",
"name": [
"Canada\u2019s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada",
"Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, Canada"
],
"type": "Organization"
},
"familyName": "Marra",
"givenName": "Marco A.",
"id": "sg:person.01150455763.02",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150455763.02"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "School of Population and Public Health, University of British Columbia, Vancouver, Canada",
"id": "http://www.grid.ac/institutes/grid.17091.3e",
"name": [
"Canadian Centre for Applied Research in Cancer Control, Cancer Control Research, BC Cancer Research Centre, 675 West 10th Avenue, V5Z 1L3, Vancouver, BC, Canada",
"School of Population and Public Health, University of British Columbia, Vancouver, Canada"
],
"type": "Organization"
},
"familyName": "Regier",
"givenName": "Dean A.",
"id": "sg:person.0663175545.54",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663175545.54"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1038/s41431-018-0203-6",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1105209060",
"https://doi.org/10.1038/s41431-018-0203-6"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/s41591-020-1072-4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1131432668",
"https://doi.org/10.1038/s41591-020-1072-4"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/s13073-021-00897-9",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1138157326",
"https://doi.org/10.1186/s13073-021-00897-9"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/s41591-019-0424-4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1113619987",
"https://doi.org/10.1038/s41591-019-0424-4"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s40273-017-0509-1",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1085000869",
"https://doi.org/10.1007/s40273-017-0509-1"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nm.4333",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1085214027",
"https://doi.org/10.1038/nm.4333"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s40273-021-01010-z",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1137256919",
"https://doi.org/10.1007/s40273-021-01010-z"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nrg.2016.49",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033123702",
"https://doi.org/10.1038/nrg.2016.49"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/s12885-016-2835-7",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1045777717",
"https://doi.org/10.1186/s12885-016-2835-7"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/1471-2407-14-586",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1005873826",
"https://doi.org/10.1186/1471-2407-14-586"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/s43018-020-0050-6",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1126633656",
"https://doi.org/10.1038/s43018-020-0050-6"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/gim.2017.247",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1101040746",
"https://doi.org/10.1038/gim.2017.247"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.2165/00019053-199813030-00002",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1040594423",
"https://doi.org/10.2165/00019053-199813030-00002"
],
"type": "CreativeWork"
}
],
"datePublished": "2021-11-29",
"datePublishedReg": "2021-11-29",
"description": "Genomic research is driving discovery for future population benefit. Limited evidence exists on immediate patient and health system impacts of research participation. This study uses real-world data and quasi-experimental matching to examine early-stage cost and health impacts of research-based genomic sequencing. British Columbia\u2019s Personalized OncoGenomics (POG) single-arm program applies whole genome and transcriptome analysis (WGTA) to characterize genomic landscapes in advanced cancers. Our cohort includes POG patients enrolled between 2014 and 2015 and 1:1 genetic algorithm\u2013matched usual care controls. We undertake a cost consequence analysis and estimate 1-year effects of WGTA on patient management, patient survival, and health system costs reported in 2015 Canadian dollars. WGTA costs are imputed and forecast using system of equations modeling. We use Kaplan-Meier survival analysis to explore survival differences and inverse probability of censoring weighted linear regression to estimate mean 1-year survival times and costs. Non-parametric bootstrapping simulates sampling distributions and enables scenario analysis, revealing drivers of incremental costs, survival, and net monetary benefit for assumed willingness to pay thresholds. We identified 230 POG patients and 230 matched controls for cohort inclusion. The mean period cost of research-funded WGTA was $26,211 (SD: $14,191). Sequencing costs declined rapidly, with WGTA forecasts hitting $13,741 in 2021. The incremental healthcare system effect (non-research expenditures) was $5203 (95% CI: 75, 10,424) compared to usual care. No overall survival differences were observed, but outcome heterogeneity was present. POG patients receiving WGTA-informed treatment experienced incremental survival gains of 2.49\u00a0months (95% CI: 1.32, 3.64). Future cost consequences became favorable as WGTA cost drivers declined and WGTA-informed treatment rates improved to 60%. Our study demonstrates the ability of real-world data to support evaluations of only-in-research health technologies. We identify situations where precision oncology research initiatives may produce survival benefit at a cost that is within healthcare systems\u2019 willingness to pay. This economic evidence informs the early-stage healthcare impacts of precision oncology research.",
"genre": "article",
"id": "sg:pub.10.1007/s12687-021-00557-w",
"inLanguage": "en",
"isAccessibleForFree": true,
"isPartOf": [
{
"id": "sg:journal.1044626",
"issn": [
"1868-310X",
"1868-6001"
],
"name": "Journal of Community Genetics",
"publisher": "Springer Nature",
"type": "Periodical"
}
],
"keywords": [
"POG patients",
"survival differences",
"Kaplan-Meier survival analysis",
"incremental survival gains",
"usual care control",
"advanced cancer care",
"overall survival difference",
"health system costs",
"comprehensive genomic sequencing",
"cost-consequence analysis",
"net monetary benefit",
"health system impacts",
"non-parametric bootstrapping",
"immediate patients",
"usual care",
"survival benefit",
"advanced cancer",
"care control",
"patient survival",
"cohort inclusion",
"survival gain",
"cancer care",
"patient management",
"outcome heterogeneity",
"survival time",
"assumed willingness",
"healthcare impact",
"survival analysis",
"patients",
"economic evidence",
"economic analysis",
"monetary benefits",
"treatment rates",
"Canadian dollars",
"inverse probability",
"period cost",
"incremental cost",
"limited evidence",
"oncology research",
"precision oncology research",
"population benefits",
"healthcare system",
"genomic sequencing",
"cost consequences",
"health impacts",
"scenario analysis",
"cost drivers",
"health technologies",
"research participation",
"genomic landscape",
"care",
"survival",
"willingness",
"system effects",
"forecasts",
"cost",
"real-world data",
"system cost",
"linear regression",
"cohort",
"cancer",
"system impact",
"impact",
"months",
"evidence",
"benefits",
"consequence analysis",
"dollars",
"drivers",
"treatment",
"differences",
"sequencing",
"control",
"WGTA",
"study",
"transcriptome analysis",
"effect",
"research initiatives",
"regression",
"system of equations",
"bootstrapping",
"management",
"analysis",
"data",
"evaluation",
"heterogeneity",
"rate",
"censoring",
"participation",
"probability",
"gain",
"whole genome",
"initiatives",
"research",
"program",
"threshold",
"ability",
"inclusion",
"consequences",
"situation",
"discovery",
"time",
"genomic research",
"system",
"matching",
"distribution",
"technology",
"genome",
"landscape",
"sequencing costs",
"equations"
],
"name": "Early-stage economic analysis of research-based comprehensive genomic sequencing for advanced cancer care",
"pagination": "1-16",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1143446021"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s12687-021-00557-w"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"34843087"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s12687-021-00557-w",
"https://app.dimensions.ai/details/publication/pub.1143446021"
],
"sdDataset": "articles",
"sdDatePublished": "2022-05-10T10:30",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_898.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/s12687-021-00557-w"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12687-021-00557-w'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12687-021-00557-w'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12687-021-00557-w'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12687-021-00557-w'
This table displays all metadata directly associated to this object as RDF triples.
314 TRIPLES
22 PREDICATES
148 URIs
127 LITERALS
5 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1007/s12687-021-00557-w | schema:about | anzsrc-for:06 |
2 | ″ | ″ | anzsrc-for:0604 |
3 | ″ | schema:author | Nf645a9c525114028bc2d36c11d922482 |
4 | ″ | schema:citation | sg:pub.10.1007/s40273-017-0509-1 |
5 | ″ | ″ | sg:pub.10.1007/s40273-021-01010-z |
6 | ″ | ″ | sg:pub.10.1038/gim.2017.247 |
7 | ″ | ″ | sg:pub.10.1038/nm.4333 |
8 | ″ | ″ | sg:pub.10.1038/nrg.2016.49 |
9 | ″ | ″ | sg:pub.10.1038/s41431-018-0203-6 |
10 | ″ | ″ | sg:pub.10.1038/s41591-019-0424-4 |
11 | ″ | ″ | sg:pub.10.1038/s41591-020-1072-4 |
12 | ″ | ″ | sg:pub.10.1038/s43018-020-0050-6 |
13 | ″ | ″ | sg:pub.10.1186/1471-2407-14-586 |
14 | ″ | ″ | sg:pub.10.1186/s12885-016-2835-7 |
15 | ″ | ″ | sg:pub.10.1186/s13073-021-00897-9 |
16 | ″ | ″ | sg:pub.10.2165/00019053-199813030-00002 |
17 | ″ | schema:datePublished | 2021-11-29 |
18 | ″ | schema:datePublishedReg | 2021-11-29 |
19 | ″ | schema:description | Genomic research is driving discovery for future population benefit. Limited evidence exists on immediate patient and health system impacts of research participation. This study uses real-world data and quasi-experimental matching to examine early-stage cost and health impacts of research-based genomic sequencing. British Columbia’s Personalized OncoGenomics (POG) single-arm program applies whole genome and transcriptome analysis (WGTA) to characterize genomic landscapes in advanced cancers. Our cohort includes POG patients enrolled between 2014 and 2015 and 1:1 genetic algorithm–matched usual care controls. We undertake a cost consequence analysis and estimate 1-year effects of WGTA on patient management, patient survival, and health system costs reported in 2015 Canadian dollars. WGTA costs are imputed and forecast using system of equations modeling. We use Kaplan-Meier survival analysis to explore survival differences and inverse probability of censoring weighted linear regression to estimate mean 1-year survival times and costs. Non-parametric bootstrapping simulates sampling distributions and enables scenario analysis, revealing drivers of incremental costs, survival, and net monetary benefit for assumed willingness to pay thresholds. We identified 230 POG patients and 230 matched controls for cohort inclusion. The mean period cost of research-funded WGTA was $26,211 (SD: $14,191). Sequencing costs declined rapidly, with WGTA forecasts hitting $13,741 in 2021. The incremental healthcare system effect (non-research expenditures) was $5203 (95% CI: 75, 10,424) compared to usual care. No overall survival differences were observed, but outcome heterogeneity was present. POG patients receiving WGTA-informed treatment experienced incremental survival gains of 2.49 months (95% CI: 1.32, 3.64). Future cost consequences became favorable as WGTA cost drivers declined and WGTA-informed treatment rates improved to 60%. Our study demonstrates the ability of real-world data to support evaluations of only-in-research health technologies. We identify situations where precision oncology research initiatives may produce survival benefit at a cost that is within healthcare systems’ willingness to pay. This economic evidence informs the early-stage healthcare impacts of precision oncology research. |
20 | ″ | schema:genre | article |
21 | ″ | schema:inLanguage | en |
22 | ″ | schema:isAccessibleForFree | true |
23 | ″ | schema:isPartOf | sg:journal.1044626 |
24 | ″ | schema:keywords | Canadian dollars |
25 | ″ | ″ | Kaplan-Meier survival analysis |
26 | ″ | ″ | POG patients |
27 | ″ | ″ | WGTA |
28 | ″ | ″ | ability |
29 | ″ | ″ | advanced cancer |
30 | ″ | ″ | advanced cancer care |
31 | ″ | ″ | analysis |
32 | ″ | ″ | assumed willingness |
33 | ″ | ″ | benefits |
34 | ″ | ″ | bootstrapping |
35 | ″ | ″ | cancer |
36 | ″ | ″ | cancer care |
37 | ″ | ″ | care |
38 | ″ | ″ | care control |
39 | ″ | ″ | censoring |
40 | ″ | ″ | cohort |
41 | ″ | ″ | cohort inclusion |
42 | ″ | ″ | comprehensive genomic sequencing |
43 | ″ | ″ | consequence analysis |
44 | ″ | ″ | consequences |
45 | ″ | ″ | control |
46 | ″ | ″ | cost |
47 | ″ | ″ | cost consequences |
48 | ″ | ″ | cost drivers |
49 | ″ | ″ | cost-consequence analysis |
50 | ″ | ″ | data |
51 | ″ | ″ | differences |
52 | ″ | ″ | discovery |
53 | ″ | ″ | distribution |
54 | ″ | ″ | dollars |
55 | ″ | ″ | drivers |
56 | ″ | ″ | economic analysis |
57 | ″ | ″ | economic evidence |
58 | ″ | ″ | effect |
59 | ″ | ″ | equations |
60 | ″ | ″ | evaluation |
61 | ″ | ″ | evidence |
62 | ″ | ″ | forecasts |
63 | ″ | ″ | gain |
64 | ″ | ″ | genome |
65 | ″ | ″ | genomic landscape |
66 | ″ | ″ | genomic research |
67 | ″ | ″ | genomic sequencing |
68 | ″ | ″ | health impacts |
69 | ″ | ″ | health system costs |
70 | ″ | ″ | health system impacts |
71 | ″ | ″ | health technologies |
72 | ″ | ″ | healthcare impact |
73 | ″ | ″ | healthcare system |
74 | ″ | ″ | heterogeneity |
75 | ″ | ″ | immediate patients |
76 | ″ | ″ | impact |
77 | ″ | ″ | inclusion |
78 | ″ | ″ | incremental cost |
79 | ″ | ″ | incremental survival gains |
80 | ″ | ″ | initiatives |
81 | ″ | ″ | inverse probability |
82 | ″ | ″ | landscape |
83 | ″ | ″ | limited evidence |
84 | ″ | ″ | linear regression |
85 | ″ | ″ | management |
86 | ″ | ″ | matching |
87 | ″ | ″ | monetary benefits |
88 | ″ | ″ | months |
89 | ″ | ″ | net monetary benefit |
90 | ″ | ″ | non-parametric bootstrapping |
91 | ″ | ″ | oncology research |
92 | ″ | ″ | outcome heterogeneity |
93 | ″ | ″ | overall survival difference |
94 | ″ | ″ | participation |
95 | ″ | ″ | patient management |
96 | ″ | ″ | patient survival |
97 | ″ | ″ | patients |
98 | ″ | ″ | period cost |
99 | ″ | ″ | population benefits |
100 | ″ | ″ | precision oncology research |
101 | ″ | ″ | probability |
102 | ″ | ″ | program |
103 | ″ | ″ | rate |
104 | ″ | ″ | real-world data |
105 | ″ | ″ | regression |
106 | ″ | ″ | research |
107 | ″ | ″ | research initiatives |
108 | ″ | ″ | research participation |
109 | ″ | ″ | scenario analysis |
110 | ″ | ″ | sequencing |
111 | ″ | ″ | sequencing costs |
112 | ″ | ″ | situation |
113 | ″ | ″ | study |
114 | ″ | ″ | survival |
115 | ″ | ″ | survival analysis |
116 | ″ | ″ | survival benefit |
117 | ″ | ″ | survival differences |
118 | ″ | ″ | survival gain |
119 | ″ | ″ | survival time |
120 | ″ | ″ | system |
121 | ″ | ″ | system cost |
122 | ″ | ″ | system effects |
123 | ″ | ″ | system impact |
124 | ″ | ″ | system of equations |
125 | ″ | ″ | technology |
126 | ″ | ″ | threshold |
127 | ″ | ″ | time |
128 | ″ | ″ | transcriptome analysis |
129 | ″ | ″ | treatment |
130 | ″ | ″ | treatment rates |
131 | ″ | ″ | usual care |
132 | ″ | ″ | usual care control |
133 | ″ | ″ | whole genome |
134 | ″ | ″ | willingness |
135 | ″ | schema:name | Early-stage economic analysis of research-based comprehensive genomic sequencing for advanced cancer care |
136 | ″ | schema:pagination | 1-16 |
137 | ″ | schema:productId | N529c8329223f4cc58061dfee1d6b4169 |
138 | ″ | ″ | N5516231d45744cc7adf8f0794391edd0 |
139 | ″ | ″ | N9456d3adc1f242caa98dd9f8a489b7ce |
140 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1143446021 |
141 | ″ | ″ | https://doi.org/10.1007/s12687-021-00557-w |
142 | ″ | schema:sdDatePublished | 2022-05-10T10:30 |
143 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
144 | ″ | schema:sdPublisher | Ne812afdb31c14318b434a51b87956d95 |
145 | ″ | schema:url | https://doi.org/10.1007/s12687-021-00557-w |
146 | ″ | sgo:license | sg:explorer/license/ |
147 | ″ | sgo:sdDataset | articles |
148 | ″ | rdf:type | schema:ScholarlyArticle |
149 | N0d369f872e474752976bdc52300764c3 | rdf:first | sg:person.011076371162.80 |
150 | ″ | rdf:rest | N4eec4a9bc1634b88a06a0877aaabc7d1 |
151 | N16b8b4a8098a46cca3494b597693938d | rdf:first | sg:person.01022072546.74 |
152 | ″ | rdf:rest | Nc585c2c894c346be8338435d05a4f290 |
153 | N294027f7b9314c3f8468db11963698a3 | rdf:first | sg:person.0745471507.67 |
154 | ″ | rdf:rest | N7817ec5613df4af398fdbaba38305f8a |
155 | N4eec4a9bc1634b88a06a0877aaabc7d1 | rdf:first | sg:person.014777661137.06 |
156 | ″ | rdf:rest | N16b8b4a8098a46cca3494b597693938d |
157 | N50085c04ea4e4f7980bc27389bdcf7cb | rdf:first | sg:person.01252152351.58 |
158 | ″ | rdf:rest | N0d369f872e474752976bdc52300764c3 |
159 | N521443cb7a1f4e45a67eac11af32cd33 | rdf:first | sg:person.0663175545.54 |
160 | ″ | rdf:rest | rdf:nil |
161 | N529c8329223f4cc58061dfee1d6b4169 | schema:name | dimensions_id |
162 | ″ | schema:value | pub.1143446021 |
163 | ″ | rdf:type | schema:PropertyValue |
164 | N5516231d45744cc7adf8f0794391edd0 | schema:name | doi |
165 | ″ | schema:value | 10.1007/s12687-021-00557-w |
166 | ″ | rdf:type | schema:PropertyValue |
167 | N7817ec5613df4af398fdbaba38305f8a | rdf:first | sg:person.01150455763.02 |
168 | ″ | rdf:rest | N521443cb7a1f4e45a67eac11af32cd33 |
169 | N87f17d54c16a44749661258d303b6651 | rdf:first | sg:person.01330657763.71 |
170 | ″ | rdf:rest | Nd3a5cc4b6f46484e98509891d2feb765 |
171 | N9456d3adc1f242caa98dd9f8a489b7ce | schema:name | pubmed_id |
172 | ″ | schema:value | 34843087 |
173 | ″ | rdf:type | schema:PropertyValue |
174 | Nc585c2c894c346be8338435d05a4f290 | rdf:first | sg:person.0757004616.26 |
175 | ″ | rdf:rest | N87f17d54c16a44749661258d303b6651 |
176 | Nd3a5cc4b6f46484e98509891d2feb765 | rdf:first | sg:person.0643127034.07 |
177 | ″ | rdf:rest | N294027f7b9314c3f8468db11963698a3 |
178 | Ne812afdb31c14318b434a51b87956d95 | schema:name | Springer Nature - SN SciGraph project |
179 | ″ | rdf:type | schema:Organization |
180 | Nf645a9c525114028bc2d36c11d922482 | rdf:first | sg:person.01115505661.36 |
181 | ″ | rdf:rest | N50085c04ea4e4f7980bc27389bdcf7cb |
182 | anzsrc-for:06 | schema:inDefinedTermSet | anzsrc-for: |
183 | ″ | schema:name | Biological Sciences |
184 | ″ | rdf:type | schema:DefinedTerm |
185 | anzsrc-for:0604 | schema:inDefinedTermSet | anzsrc-for: |
186 | ″ | schema:name | Genetics |
187 | ″ | rdf:type | schema:DefinedTerm |
188 | sg:journal.1044626 | schema:issn | 1868-310X |
189 | ″ | ″ | 1868-6001 |
190 | ″ | schema:name | Journal of Community Genetics |
191 | ″ | schema:publisher | Springer Nature |
192 | ″ | rdf:type | schema:Periodical |
193 | sg:person.01022072546.74 | schema:affiliation | grid-institutes:grid.17091.3e |
194 | ″ | schema:familyName | Lim |
195 | ″ | schema:givenName | Howard J. |
196 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022072546.74 |
197 | ″ | rdf:type | schema:Person |
198 | sg:person.011076371162.80 | schema:affiliation | grid-institutes:grid.61971.38 |
199 | ″ | schema:familyName | Jones |
200 | ″ | schema:givenName | Steven J. M. |
201 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011076371162.80 |
202 | ″ | rdf:type | schema:Person |
203 | sg:person.01115505661.36 | schema:affiliation | grid-institutes:grid.248762.d |
204 | ″ | schema:familyName | Weymann |
205 | ″ | schema:givenName | Deirdre |
206 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01115505661.36 |
207 | ″ | rdf:type | schema:Person |
208 | sg:person.01150455763.02 | schema:affiliation | grid-institutes:grid.17091.3e |
209 | ″ | schema:familyName | Marra |
210 | ″ | schema:givenName | Marco A. |
211 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150455763.02 |
212 | ″ | rdf:type | schema:Person |
213 | sg:person.01252152351.58 | schema:affiliation | grid-institutes:grid.17091.3e |
214 | ″ | schema:familyName | Laskin |
215 | ″ | schema:givenName | Janessa |
216 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252152351.58 |
217 | ″ | rdf:type | schema:Person |
218 | sg:person.01330657763.71 | schema:affiliation | grid-institutes:None |
219 | ″ | schema:familyName | Schrader |
220 | ″ | schema:givenName | Kasmintan A. |
221 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330657763.71 |
222 | ″ | rdf:type | schema:Person |
223 | sg:person.014777661137.06 | schema:affiliation | grid-institutes:grid.434706.2 |
224 | ″ | schema:familyName | Roscoe |
225 | ″ | schema:givenName | Robyn |
226 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014777661137.06 |
227 | ″ | rdf:type | schema:Person |
228 | sg:person.0643127034.07 | schema:affiliation | grid-institutes:grid.17091.3e |
229 | ″ | schema:familyName | Sun |
230 | ″ | schema:givenName | Sophie |
231 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643127034.07 |
232 | ″ | rdf:type | schema:Person |
233 | sg:person.0663175545.54 | schema:affiliation | grid-institutes:grid.17091.3e |
234 | ″ | schema:familyName | Regier |
235 | ″ | schema:givenName | Dean A. |
236 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663175545.54 |
237 | ″ | rdf:type | schema:Person |
238 | sg:person.0745471507.67 | schema:affiliation | grid-institutes:None |
239 | ″ | schema:familyName | Yip |
240 | ″ | schema:givenName | Stephen |
241 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0745471507.67 |
242 | ″ | rdf:type | schema:Person |
243 | sg:person.0757004616.26 | schema:affiliation | grid-institutes:grid.17091.3e |
244 | ″ | schema:familyName | Renouf |
245 | ″ | schema:givenName | Daniel J. |
246 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0757004616.26 |
247 | ″ | rdf:type | schema:Person |
248 | sg:pub.10.1007/s40273-017-0509-1 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1085000869 |
249 | ″ | ″ | https://doi.org/10.1007/s40273-017-0509-1 |
250 | ″ | rdf:type | schema:CreativeWork |
251 | sg:pub.10.1007/s40273-021-01010-z | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1137256919 |
252 | ″ | ″ | https://doi.org/10.1007/s40273-021-01010-z |
253 | ″ | rdf:type | schema:CreativeWork |
254 | sg:pub.10.1038/gim.2017.247 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1101040746 |
255 | ″ | ″ | https://doi.org/10.1038/gim.2017.247 |
256 | ″ | rdf:type | schema:CreativeWork |
257 | sg:pub.10.1038/nm.4333 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1085214027 |
258 | ″ | ″ | https://doi.org/10.1038/nm.4333 |
259 | ″ | rdf:type | schema:CreativeWork |
260 | sg:pub.10.1038/nrg.2016.49 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1033123702 |
261 | ″ | ″ | https://doi.org/10.1038/nrg.2016.49 |
262 | ″ | rdf:type | schema:CreativeWork |
263 | sg:pub.10.1038/s41431-018-0203-6 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1105209060 |
264 | ″ | ″ | https://doi.org/10.1038/s41431-018-0203-6 |
265 | ″ | rdf:type | schema:CreativeWork |
266 | sg:pub.10.1038/s41591-019-0424-4 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1113619987 |
267 | ″ | ″ | https://doi.org/10.1038/s41591-019-0424-4 |
268 | ″ | rdf:type | schema:CreativeWork |
269 | sg:pub.10.1038/s41591-020-1072-4 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1131432668 |
270 | ″ | ″ | https://doi.org/10.1038/s41591-020-1072-4 |
271 | ″ | rdf:type | schema:CreativeWork |
272 | sg:pub.10.1038/s43018-020-0050-6 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1126633656 |
273 | ″ | ″ | https://doi.org/10.1038/s43018-020-0050-6 |
274 | ″ | rdf:type | schema:CreativeWork |
275 | sg:pub.10.1186/1471-2407-14-586 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1005873826 |
276 | ″ | ″ | https://doi.org/10.1186/1471-2407-14-586 |
277 | ″ | rdf:type | schema:CreativeWork |
278 | sg:pub.10.1186/s12885-016-2835-7 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1045777717 |
279 | ″ | ″ | https://doi.org/10.1186/s12885-016-2835-7 |
280 | ″ | rdf:type | schema:CreativeWork |
281 | sg:pub.10.1186/s13073-021-00897-9 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1138157326 |
282 | ″ | ″ | https://doi.org/10.1186/s13073-021-00897-9 |
283 | ″ | rdf:type | schema:CreativeWork |
284 | sg:pub.10.2165/00019053-199813030-00002 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1040594423 |
285 | ″ | ″ | https://doi.org/10.2165/00019053-199813030-00002 |
286 | ″ | rdf:type | schema:CreativeWork |
287 | grid-institutes:None | schema:alternateName | Department of Molecular Oncology, BC Cancer, Vancouver, Canada |
288 | ″ | ″ | Department of Pathology, BC Cancer, Vancouver, Canada |
289 | ″ | schema:name | Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, Canada |
290 | ″ | ″ | Department of Molecular Oncology, BC Cancer, Vancouver, Canada |
291 | ″ | ″ | Department of Pathology & Laboratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada |
292 | ″ | ″ | Department of Pathology, BC Cancer, Vancouver, Canada |
293 | ″ | rdf:type | schema:Organization |
294 | grid-institutes:grid.17091.3e | schema:alternateName | Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, Canada |
295 | ″ | ″ | Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada |
296 | ″ | ″ | School of Population and Public Health, University of British Columbia, Vancouver, Canada |
297 | ″ | schema:name | Canada’s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada |
298 | ″ | ″ | Canadian Centre for Applied Research in Cancer Control, Cancer Control Research, BC Cancer Research Centre, 675 West 10th Avenue, V5Z 1L3, Vancouver, BC, Canada |
299 | ″ | ″ | Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, Canada |
300 | ″ | ″ | Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada |
301 | ″ | ″ | Division of Medical Oncology, BC Cancer, Vancouver, Canada |
302 | ″ | ″ | School of Population and Public Health, University of British Columbia, Vancouver, Canada |
303 | ″ | rdf:type | schema:Organization |
304 | grid-institutes:grid.248762.d | schema:alternateName | Canadian Centre for Applied Research in Cancer Control, Cancer Control Research, BC Cancer Research Centre, 675 West 10th Avenue, V5Z 1L3, Vancouver, BC, Canada |
305 | ″ | schema:name | Canadian Centre for Applied Research in Cancer Control, Cancer Control Research, BC Cancer Research Centre, 675 West 10th Avenue, V5Z 1L3, Vancouver, BC, Canada |
306 | ″ | rdf:type | schema:Organization |
307 | grid-institutes:grid.434706.2 | schema:alternateName | Canada’s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada |
308 | ″ | schema:name | Canada’s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada |
309 | ″ | rdf:type | schema:Organization |
310 | grid-institutes:grid.61971.38 | schema:alternateName | Department of Molecular Biology & Biochemistry, Simon Fraser University, Burnaby, Canada |
311 | ″ | schema:name | Canada’s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada |
312 | ″ | ″ | Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, Canada |
313 | ″ | ″ | Department of Molecular Biology & Biochemistry, Simon Fraser University, Burnaby, Canada |
314 | ″ | rdf:type | schema:Organization |